When Your Medication Is Recalled or Unavailable: What Compounding Can Do

If your medication has been recalled or you’ve been told it’s no longer available, you’re not alone, and you may have more options than you realize. Australia’s pharmaceutical supply chain faces genuine disruptions: global shortages, TGA safety recalls, manufacturer discontinuations, and regulatory changes that can leave patients without access to medicines they’ve relied on for years.

For a subset of these situations, compounding pharmacies fill a critical gap. This article explains how the recall and shortage process works in Australia, what compounding can and cannot do, and what to do if your specific medication has been affected.

What Happens When a Medication Is Recalled in Australia?

Medication recalls in Australia are managed by the Therapeutic Goods Administration (TGA), the national regulator responsible for the safety and quality of all therapeutic goods. When a safety concern is identified, such as a contamination, a manufacturing defect, or a detected impurity, the TGA can issue a recall notice requiring the product to be withdrawn from the market.

There are three classes of TGA recall:

• Class I: The most serious, use of the product may cause serious health consequences or death. Immediate action is required.
• Class II: The product may cause temporary adverse health effects but is unlikely to cause serious harm.
• Class III: Use of the product is unlikely to cause harm, but the recall is issued for other reasons (such as mislabelling or non-compliance).

When a Class I or Class II recall is issued, affected batches are withdrawn from pharmacies and distributors. Patients who have dispensed the recalled product are typically advised to return it and work with their GP to find an alternative.

Why Do Some Medications Become Unavailable in Australia?

Recalls are one cause of medication unavailability, but they are not the only one. Patients and prescribers encounter unavailable medications for a range of reasons:

• Global manufacturing shortages

  Many active pharmaceutical ingredients (APIs) are manufactured at a small number of facilities globally, often in India or China. A factory disruption, regulatory action, or raw material shortage can ripple into markets worldwide.

• Commercial discontinuation

  A manufacturer may simply decide that a medicine is no longer commercially viable in the Australian market and withdraw it. This often affects medicines used by smaller patient populations.

• Regulatory changes

  Changes to TGA scheduling, PBS listing status, or import requirements can affect access to medicines that were previously available.

• TGA safety recalls

  As described above, quality or safety concerns trigger formal withdrawal.

• Supply chain disruptions

  Transport issues, border delays, or demand spikes (as seen during COVID-19) can create temporary shortages even without an underlying quality issue.

The TGA’s Medicine Shortage Database and Medicine Recall Database are publicly accessible resources that list current shortages and recalls by product name.

How Compounding Pharmacies Fill the Gap

When a commercial medication becomes unavailable, compounding pharmacies can, in some circumstances, prepare an equivalent alternative using the same active ingredient. This is one of the core clinical roles of compounding pharmacy in the Australian healthcare system.

The key conditions that make compounding a viable alternative are:

• The active ingredient is available to licensed compounding pharmacies as a pharmaceutical-grade API.
• A valid prescription has been issued by a registered Australian medical practitioner.
• The compounding pharmacy is accredited and operating under current GMP (Good Manufacturing Practice) or OTC manufacturing standards relevant to the formulation.

Compounding does not replicate commercial manufacturing. Each batch is prepared to order for a specific patient. This means the dose, formulation, and delivery form can be customized, but the preparation takes time, and not every commercial product has a directly equivalent compoundable alternative.

What compounding can often provide:

• The same active ingredient in the same or equivalent dose, prepared in a comparable delivery form (capsule, cream, liquid)
• Alternative delivery forms, for example, if the recalled product was a tablet, it may be possible to compound it as a liquid for patients who cannot swallow tablets
• Custom combinations of active ingredients that were previously available as a single commercial product

What compounding cannot always provide:

• An exact replica of a complex modified-release or biological product (these typically cannot be compounded)
• Immediate availability. Compounded medicines are made to order and require a lead time
• The same inactive ingredients as the original product. Your formulation may have a different base, flavour, or excipient profile

If your medication has been recalled or discontinued, the first step is to contact your prescribing doctor. They can assess whether a compounded alternative is clinically appropriate for your situation and issue the necessary prescription.

Case Study: Ranitidine (Zantac) and the NDMA Recall

The ranitidine recall of 2019–2020 is one of the most widely reported medication withdrawal events in recent Australian history, and it illustrates exactly how the system works and where compounding pharmacies fit into the response.

Ranitidine (brand name Zantac) is an H2 blocker used to reduce stomach acid, commonly prescribed for gastroesophageal reflux disease (GORD), peptic ulcer disease, and related conditions. In 2019, regulatory agencies in multiple countries, including the TGA in Australia, identified that ranitidine products contained detectable levels of N-nitrosodimethylamine (NDMA), a probable human carcinogen.

The TGA issued a recall covering most ranitidine products on the Australian market. Patients on long-term ranitidine were advised to work with their GP to transition to an alternative. The main commercial alternatives were famotidine (another H2 blocker) and proton pump inhibitors (PPIs) such as omeprazole or pantoprazole.

For some patients, particularly those who had tried other H2 blockers or PPIs without adequate symptom control, a compounded ranitidine formulation became relevant during the transition period, as compounding pharmacies sourcing pharmaceutical-grade ranitidine API from compliant suppliers were still able to prepare it for prescription. This is a narrow but real application of compounding in a recall scenario.

The broader lesson from the ranitidine situation applies to any recall: the commercial supply was disrupted, patients needed alternatives, and compounding was one part of the clinical response, not a complete solution, but a meaningful option for some patients.

What to Do If Your Medication Has Been Recalled or Discontinued

If you have been affected by a medication recall or shortage, here are the steps we recommend:

• Step 1: Contact your prescribing doctor. Do not stop taking your medication abruptly without medical advice. Discuss alternatives or transition plans with your GP or specialist first.
• Step 2: Check the TGA databases. The TGA Medicine Shortage Database and Recall Database are publicly accessible and updated regularly. Knowing the reason for the shortage helps your doctor plan the best alternative.
• Step 3: Ask your doctor whether compounding is an option. If the active ingredient in your medication is available as a pharmaceutical-grade API, NCC may be able to compound an alternative. Your doctor can prescribe specifically for a compounded formulation.
• Step 4: Contact NCC with your prescription. Once your doctor has issued a prescription for a compounded alternative, you can upload it via our online order system or contact our team to discuss your specific medication. We will advise on what we can prepare and our expected turnaround.

NCC compounds medications for patients across Australia in response to recalled, discontinued, and commercially unavailable products. Not every recalled medicine has a compoundable alternative, but many do, and our team is experienced in identifying what is possible for a given prescription.

Frequently Asked Questions Regarding Medication Recalls and Compounding Alternatives

If my medication is recalled, is compounding always an option?

Not always. Compounding is possible when the active ingredient is available as pharmaceutical-grade API and a prescribing doctor has issued a valid prescription. For complex biologics, modified-release systems, or medications where the API itself is unavailable, compounding may not be feasible. Contact NCC with your specific medication details to confirm whether an alternative can be prepared.

How long does it take to get a compounded alternative after a recall?

Compounded medications are made to order. Turnaround times depend on the formulation and current demand, but most standard compounded preparations can be dispatched within 2–5 business days of receiving a valid prescription. Contact NCC early, ideally before your existing supply runs out, to allow adequate lead time.

Will a compounded alternative be identical to the recalled product?

The active ingredient and dose can be equivalent, but the compounded preparation may differ in inactive ingredients, appearance, flavour, or delivery form compared to the original commercial product. Your pharmacist can discuss what to expect and how the formulation compares to what you were previously taking.

Where can I check if my medication has been recalled in Australia?

The TGA Recalls and Alerts database is publicly accessible at tga.gov.au. You can search by product name, active ingredient, or sponsor. The Medicine Shortage Database on the same site lists current supply disruptions. Your pharmacist is also an excellent resource, they are typically notified of recalls before patients are and can advise on next steps.

Can my doctor prescribe a compounded version of a medication that has been discontinued commercially?

Yes, in many cases. If a commercial product has been discontinued (rather than recalled for safety reasons), compounding an equivalent formulation is often clinically and legally appropriate. Your doctor would prescribe the active ingredient, dose, and delivery form, and NCC would prepare the compounded medicine to that prescription.